Moderna: FDA delaying decision on its shot for adolescents
U.S. regulators are delaying their decision on Moderna's COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.
Nov 1, 2021
0
2